ArticleTherapeutic advances in medical oncology2024

Targeting mTOR signaling for the treatment of intrahepatic cholangiocarcinoma with TSC1/ARID1A mutations: a case report with an unexpected response.

Clémentine Daugan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.